Price $1.21 |
Market Cap
27.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.16
|
P/S
37.45
|
Dividend %
-
|
|
P/CF
402.0
|
P/FCF
-
|
Op. Cash Flow
900
|
FCF
-
|
|
Op. Margin
-235.90%
|
Net Margin
-301.10%
|
ROE
-36.40%
|
ROI
-1.80%
|
|
ROA
-14.90%
|
EPS Growth
34.40%
|
Current Ratio
0.7
|
Debt/Equity
71.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AEterna Zentaris Inc. (USA) (AEZS) | $0.85 | - | - | 133.3M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $66.08 | - | 3.10% | 141.03B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.97 | - | - | 45.2M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.67 | - | - | 2.02B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
